Jump to contents

Researcher Information

last modified:2017/08/03

Professor KINUYA Seigo

Mail Laboratory Website

Faculty, Affiliation

Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences
Professor
Vice President, University Hospital

College and School Educational Field

Division of Medical Sciences, Graduate School of Medical Science
Division of Cancer Medicine, Graduate School of Medical Science
School of Medicine, College of Medical, Pharmaceutical and Health Sciences

Laboratory

Department of Nuclear Medicine TEL:076-265-2333 FAX:076-234-4257

Academic Background

【Academic background(Doctoral/Master's Degree)】
Kanazawa University Doctor Internal medicine, NUclear Medicine 199003 Completed
【Academic background(Bachelor's Degree)】
Kanazawa University Medicine 198603
【Degree】
MD

Career

Kanazawa University University Hospital Vice President(2016/04/01-)
Kanazawa University University Hospital Director aide(2014/04/01-2016/03/31)
Kanazawa University University Hospital Vice President(2012/04/01-2014/03/31)
Kanazawa University Institute of Medical. Pharmaceutical and Health Sciences, Department of Nuclear Medicine Professor(2006/10/16-)
Kanazawa University University Hospital, Department of Nuclear Medicine Assisstant Professor(2006/04/01-2006/10/15)
School of Medicine, Kanazawa University Department of Nuclear Medicine Assisstant(1995/10/01-2006/03/31)
School of Medicine, Kanazawa University Department of Nuclear Medicine Staff doctor(1992/11/01-1995/09/30)
National Institutes of Health, USA Clinical Center, Deapartment of Nuclear Medicine Visiting fellow(1990/10/29-1992/10/31)
School of Medicine, Kanazawa University Department of Nuclear Medicine Staff doctor(1990/08/01-1990/10/28)
Hokuriku Central Hospital Internal Medicine Staff doctor(1990/04/01-1990/07/31)

Year & Month of Birth

Academic Society

Japanese Society of Nuclear Medicine
Society of Nuclear Medicine



Asia Oceania Federation of Nuclear Medicine and Biology
World Association of Radiopharmaceutical Therapy



JASCC

Award

○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Best Science Paper in European Journal of Nuclear Medicine(2002/09/04)
○Best Science Paper in European Journal of Nuclear Medicine(2002/09/04)

Specialities

Nuclear Medicine、、Biomolecular chemistry

Speciality Keywords

Nuclear Medicine, radionuclide therapy

Research Themes

Tumor detection and treatment with radiopharmaceuticals

Books

  •  Combined radioimmunotherapy with antiangiogenic therapy to treat cancer: validation studies in animal models Nova Science Publishers, Inc.
  •  Assessment of cancer drug resistance with nuclear medicine images Nova Science Publishers, Inc
  •  Li X-F, Bai J, Yokoyama K, Michigishi T, Tonami N Prediction of therapeutic responses to chemotherapy and monitor of effects of MDR-modulation with radiotracers in malignant tumors Nova Science Publishers, Inc 2006/11

Papers

  •  177Lu-EDTMP: A potential therapeutic bone agent NUCLEAR MEDICINE COMMUNICATIONS 19 6 587-591 1998/06
  •  99mTc-tetrofosmin uptake in bone metastases from breast cancer ANNALS OF NUCLEAR MEDICINE 12 5 293-296 1998/10
  •  A case of double cancers with myocardial metastasis mimicking acute myocardial infarction both on an electrocardiogram and on Tc-99m-MIBI myocardial SPECT ANNALS OF NUCLEAR MEDICINE 15 4 381-385 2001/08
  •  Adrenal mass and renal vessels mimicking intestinal bleeding in Tc-99m red blood cell scintigraphy CLINICAL NUCLEAR MEDICINE 22 11 785-786 1997/11
  •  Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts EUROPEAN JOURNAL OF NUCLEAR MEDICINE 28 9 1306-1312 2001/09

show all

  •  Assessment of left ventricular systolic and diastolic function based on the edge detection method with myocardial ECG-gated SPET EUROPEAN JOURNAL OF NUCLEAR MEDICINE 28 10 1512-1516 2001/10
  •  Clinical approach to renal study incidental to 99mTc-MDP bone scintigraphy ANNALS OF NUCLEAR MEDICINE 15 3 237-245 2001/06
  •  Combination radioimmunotherapy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts CANCER LETTERS 140 1-2 209-218 1999/01
  •  Differential uptake of Tl-201 by small-cell lung cancer in a patient with pneumoconiosis-related pulmonary nodules CLINICAL NUCLEAR MEDICINE 24 9 687-690 1999/09
  •  Early detection of x-ray CT negative recurrent lung cancer with Tl-201 SPECT CLINICAL NUCLEAR MEDICINE 22 3 196-197 1997/03
  •  Early response of tumour to radiotherapy should be assessed by both uptake and retention of single photon tracers: In vitro analysis with 201Tl chloride, 99Tcm-sestamibi and 99Tcm-tetrofosmin in human bladder cancer cells and human leucocytes NUCLEAR MEDICINE COMMUNICATIONS 20 6 581-588 1999/06
  •  Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 125 11 630-636 1999/11
  •  Enhanced efficacy of radioimmunotherapy combined with systemic chemotherapy and local hyperthermia in xenograft model JAPANESE JOURNAL OF CANCER RESEARCH 91 5 573-578 2000/05
  •  Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement ANNALS OF NUCLEAR MEDICINE 15 2 97-101 2001/04
  •  Experimental investigation of I-123 iodoamphetamine in the detection of lung cancer LUNG CANCER 25 1 1-6 1999/01
  •  Experimental radioimmunotherapy with 186Re-MAG3-A7 anti-colorectal cancer monoclonal antibody: comparison with 131I-counterpart ANNALS OF NUCLEAR MEDICINE 15 3 199-202 2001/06
  •  Forward cardiac output measurement with first-pass technique using 99mTc-labeled myocardial perfusion imaging agents JOURNAL OF NUCLEAR MEDICINE 40 11 1874-1881 1999/11
  •  Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment EUROPEAN JOURNAL OF NUCLEAR MEDICINE 28 6 750-755 2001/06
  •  Incidential detection of pulmonary infection during the evaluation of protein losing enteropathy with In-111 transferrin. CLINICAL NUCLEAR MEDICINE 22 6 297-398 1997/06
  •  Increased uptake of 99mTc-HL91 in tumor cells exposed to X-ray radiation ANNALS OF NUCLEAR MEDICINE 14 2 139-141 2000/02
  •  Mallory-Weiss syndrome caused by radiation sickness of I-131 therapy for metastatic thyroid carcinoma JOURNAL OF NUCLEAR MEDICINE 38 11 1831 1997/11
  •  Methylxanthine sensitization of human colon cancer cells to 186Re-monoclonalantibody JOURNAL OF NUCLEAR MEDICINE 42 4 596-600 2001/04
  •  Multiple myeloma evaluated with 201Tl scintigraphy compared with bone scintigraphy JOURNAL OF NUCLEAR MEDICINE 40 7 1138-1142 1999/07
  •  Optimal timing of administration of hyperthermia in combined radioimmunotherapy Cancer Biotherapy and Radiopharmceuticals 15 4 373-379 2000/04
  •  Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitor ONCOLOGY RESEARCH 10 11-12 551-559 1998/11
  •  Pharmacological intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts. JOURNAL OF NUCLEAR MEDICINE 41 7 1244-1249 2000/07
  •  Preoperative assessment of residual hepatic function reserve using 99mTc-DTPA-galactosyl-human albumin dynamic SPECT JOURNAL OF NUCLEAR MEDICINE 40 10 1644-1651 1999/10
  •  Preparation and in vivo characteristics of 99mTc-EDTMP - comparison with 99mTc-MDP Memoirs Health Scl Med Kanazawa Univ 23 2 989-995 1999/12
  •  Prevalence of deep vein thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies ANNALS OF NUCLEAR MEDICINE 15 6 495-497 2001/12
  •  Production of 105Rh-EDTMP and its bone accumulation APPLIED RADIATION AND ISOTOPES 52 2 211-215 2000/02
  •  Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay JOURNAL OF NUCLEAR MEDICINE 39 3 436-4 1998/10
  •  Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay JOURNAL OF NUCLEAR MEDICINE 39 12 2077-2079 1998/12
  •  Relationship between hemodynamic parapeters during exercise and cardiac function Memoirs Health Scl Med Kanazawa University 21 37-44 1997/10
  •  Reversible cerebral hypoperfusion observed with Tc-99m HMPAO SPECT in reversible dementia caused by hypothyroidism CLINICAL NUCLEAR MEDICINE 24 9 666-668 1999/06
  •  Rhenium-186-mercaptoacetyltriglycine Labeled Monoclonal Antibody for Radioimmunotherapy: In vitro Assessment, in vivo Kinetics and Dosimetry in Tumor-bearing Nude Mice JAPANESE JOURNAL OF CANCER RESEARCH 89 8 870-878 1998/08
  •  Scintigraphic detection of varicoceles in infertile men Memoirs Health Scl Med Kanazawa Univ 22 29-34 1998/10
  •  Short-period-induced hypertension could improve tumor-to-nontumor ratios of radiolabeled monoclonal antibody NUCLEAR MEDICINE AND BIOLOGY 24 6 547-551 1997/06
  •  Survey of myeloblastoma with Ga-67 scan in a patient with acute leukemia CLINICAL NUCLEAR MEDICINE 22 6 434-437 1997/06
  •  Systemic-portal shunt in unilateral iliac vein stenosis. CLINICAL NUCLEAR MEDICINE 22 6 404-406 1997/06
  •  Technetium-99m-Tetrofosmin Would Be a Substrate for Multidrug Resistance-associated Protein (MRP): Comparison between a Leukemia Cell Line with High MRP Gene Expression and Its Parental Cell Line Cancer Biotherapy and Radiopharmceuticals 16 1 17-24 2001/02
  •  Thallium-201 SPECT with triple-headed gamma camera for differential diagnosis of small plumonary nodular lesion 20 mm in diameter of smaller ANNALS OF NUCLEAR MEDICINE 14 2 91-95 2000/04
  •  Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 schintigraphy RADIOLOGY 221 1 201-206 2001/10
  •  Visualization of bone structure with Tc-99m MIBI in a patient on hemodyalysis. CLINICAL NUCLEAR MEDICINE 22 5 331-332 1997/05
  •  Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice EUROPEAN JOURNAL OF NUCLEAR MEDICINE 29 8 1006 2002/08
  •  Cooperative effect of radioimmunotherapy and antiangiogenic therapy with thalidomide in human cancer xenografts JOURNAL OF NUCLEAR MEDICINE 43 8 1084 2002/08
  •  Statistical parametric mapping in brain single photon computed emission tomography after carbon monoxide intoxication NUCLEAR MEDICINE COMMUNICATIONS 23 4 355 2002/04
  •  Radionuclide cisternography in intracranical hypotension syndrome ANNALS OF NUCLEAR MEDICINE 16 1 75 2002/01
  •  Intense 201Tl uptake in giant-cell tumour of bone NUCLEAR MEDICINE COMMUNICATIONS 23 8 595 2002/08
  •  Radioimmunotherapy with 186Re-labeled monoclonal antibody to treat liver metastases of colon cancer cells in nude mice CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 17 6 681 2002/12
  •  A new method for measuring dynamic change of tracer distribution using dynamic single photon emission tomography with a slip-ring rotational gamma camera NUCLEAR MEDICINE COMMUNICATIONS 23 11 1115 2002/11
  •  Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells EUROPEAN JOURNAL OF NUCLEAR MEDICINE 29 12 1669 2002/12
  •  Anti-angiogenic therapy and radioimmuhnotherapy in colon cancer xenografts EUROPEAN JOURNAL OF NUCLEAR MEDICINE 28 9 1306 2001/09
  •  Differentiation of soft tissue hemangioma by 201Tl scintigraphy NUCLEAR MEDICINE COMMUNICATIONS 24 2 327-330 2003/02
  •  Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy JAPANESE JOURNAL OF CANCER RESEARCH 94 7 650-654 2003/07
  •  Evaluation of left and right ventricular functional parameters with automatic edge detection program of ECG gated blood SPET NUCLEAR MEDICINE COMMUNICATIONS 24 4 559-563 2003/04
  •  Estimation of fractional liver uptake and blood retention of 99mTc-DTPA-galactosyl human serum albumin NUCLEAR MEDICINE COMMUNICATIONS 24 4 503-511 2003/04
  •  Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT JOURNAL OF NUCLEAR MEDICINE 44 3 475-482 2003/03
  •  Improved survival of mice bearing liver metastases of colon cancer cells treated with combination of radioimmunotherapy and antiangiogenic therapy EUROPEAN JOURNAL OF NUCLEAR MEDICINE 31 7 981-985 2004/07
  •   Limitations of 99mTc-tetrofosmin in assessing reversal effects of verapamil on multi-drug resistance associated protein 1 (MRP1) function. NUCLEAR MEDICINE COMMUNICATIONS 25 7 585-589 2004/07
  •  Hypoxia as a factor for Ga-67 accumulation in tumor cells NUCLEAR MEDICINE COMMUNICATIONS 25 1 49-53 2004/01
  •  Role of brain perfusion single-photon emission tomography in traumatic head injury NUCLEAR MEDICINE COMMUNICATIONS 25 4 333-337 2004/04
  •  Preliminary evaluation of image reconstruction by ordered-subset expectation maximiZation in thallium-201 lung scintigraphy ANNALS OF NUCLEAR MEDICINE 17 7 619-624 2003/10
  •  Locoregional radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart CANCER LETTERS 219 1 41-48 2005/01
  •  227Th-EDTMP: a potential therapeutic agent for bone metastasis NUCLEAR MEDICINE AND BIOLOGY 31 9 901-908 2004/09
  •  Brown adipose tissue: evaluation with 201Tl and 99mTc-sestamibi dual-tracer SPECT ANNALS OF NUCLEAR MEDICINE 18 6 547-549 2004/12
  •  99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells Bai J, Shiba K, Yokoyama K, Mori H, Fukuoka M, Watanabe M, Shuke N, Michigishi T, Tonami N ANNALS OF NUCLEAR MEDICINE 20 1 29-34 2006/01
  •  Changes of 99mTc-sestamibi uptake in P-glycoprotein expressing leukemia cells treated in vivo with antisense oligodeoxynucleotide complementary to mdr-1 mRNA Bai J, Yokoyama K, Shiba K, Mori H, Fukuoka M, Watanabe N, Shuke N, Michigishi T, Tonami N World Journal of Nuclear Medicine 5 2 115-118 2006/04
  •  Intraperitoneal radioimmunotherapy to treat early phase of peritoneal dissemination of human colon cancer cells in a murine model NUCLEAR MEDICINE COMMUNICATIONS 28 2007
  •  Characterization of cartilaginous tumors with 201Tl scintigraphy. Higuchi T,Taki J,Sumiya H,Kinuya S,Nakajima K,Namura M,Tonami N Ann Nucl Med 19 2 95-9
  •  Sonographically guided core biopsy of the salivary gland masses: safety and efficacy. Taki S,Yamamoto T,Kawai A,Terahata S,Kinuya K,Tonami H Clin Imaging 29 3 189-94
  •  Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart. Kinuya S,Yokoyama K,Izumo M,Sorita T,Obata T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N Cancer Lett 219 1 41-8
  •  Time course of discordant BMIPP and thallium uptake after ischemia and reperfusion in a rat model. Higuchi T,Taki J,Nakajima K,Kinuya S,Namura M,Tonami N J Nucl Med 46 1 172-5
  •  Tc-99m MAA SPECT in pectus excavatum: assessment of perfusion volume changes after correction by the Nuss procedure. Kinuya K,Ueno T,Kobayashi T,Tuji T,Yamamoto Y,Kinuya S Clin Nucl Med 30 12 779-82
  •  Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts. Kinuya S,Yokoyama K,Fukuoka M,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N Nucl Med Commun 26 12 1067-73
  •  Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model. Yoshimoto M,Kinuya S,Kawashima A,Nishii R,Yokoyama K,Kawai K Nucl Med Biol 33 8 963-9
  •  Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer. Kinuya S,Yokoyama K,Michigishi T,Tonami N Ann Nucl Med 20 7 499-502
  •  A simple and rapid radiochemical choline acetyltransferase (ChAT) assay screening test. Shiba K,Ogawa K,Kinuya S,Yajima K,Mori H J Neurosci Methods 157 1 98-102
  •  99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells. Kinuya S,Bai J,Shiba K,Yokoyama K,Mori H,Fukuoka M,Watanabe N,Shuke N,Michigishi T,Tonami N Ann Nucl Med 20 1 29-34
  •  Binding with serum components favorably affects cellular uptake of 111In-oligonucleotide in a leukemia cell line. Bai J,Kinuya S,Shiba K,Michigishi T,Tonami N Cancer Biother Radiopharm 21 1 34-40
  •  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. Nakajima K,Matsubara K,Ishikawa T,Motomura N,Maeda R,Akhter N,Okuda K,Taki J,Kinuya S J Nucl Cardiol 14 6 843-51
  •  In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent. Akhter N,Shiba K,Ogawa K,Kinuya S,Nakajima K,Mori H Nucl Med Biol 34 6 697-702
  •  Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. Taki J,Higuchi T,Kawashima A,Fukuoka M,Kayano D,Tait JF,Matsunari I,Nakajima K,Kinuya S,Strauss HW J Nucl Med 48 8 1301-7
  •  Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy. Li Y,Li XF,Ma Y,Fang N,Russell J,Ma D,Sun X,Han X,Yang H,Kinuya S Cancer Biother Radiopharm 22 3 367-73
  •  Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model. Ogawa K,Mukai T,Asano D,Kawashima H,Kinuya S,Shiba K,Hashimoto K,Mori H,Saji H J Nucl Med 48 1 122-7
  •  Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model. Kinuya S,Yokoyama K,Fukuoka M,Hiramatsu T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N Nucl Med Commun 28 2 129-33
  •  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. Nakajima K,Matsubara K,Ishikawa T,Motomura N,Maeda R,Akhter N,Okuda K,Taki J,Kinuya S J Nucl Cardiol 14 6 843-51
  •  In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent. Akhter N,Shiba K,Ogawa K,Kinuya S,Nakajima K,Mori H Nucl Med Biol 34 6 697-702
  •  Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy. Li Y,Li XF,Ma Y,Fang N,Russell J,Ma D,Sun X,Han X,Yang H,Kinuya S Cancer Biother Radiopharm 22 3 367-73
  •  Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. Taki J,Higuchi T,Kawashima A,Fukuoka M,Kayano D,Tait JF,Matsunari I,Nakajima K,Kinuya S,Strauss HW J Nucl Med 48 8 1301-7
  •  Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model. Ogawa K,Mukai T,Asano D,Kawashima H,Kinuya S,Shiba K,Hashimoto K,Mori H,Saji H J Nucl Med 48 1 122-7
  •  Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model. Kinuya S,Yokoyama K,Fukuoka M,Hiramatsu T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N Nucl Med Commun 28 2 129-33
  •  In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent. Akhter N,Shiba K,Ogawa K,Kinuya S,Nakajima K,Mori H Nucl Med Biol 34 6 697-702
  •  Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy. Li Y,Li XF,Ma Y,Fang N,Russell J,Ma D,Sun X,Han X,Yang H,Kinuya S Cancer Biother Radiopharm 22 3 367-73
  •  Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. Taki J,Higuchi T,Kawashima A,Fukuoka M,Kayano D,Tait JF,Matsunari I,Nakajima K,Kinuya S,Strauss HW J Nucl Med 48 8 1301-7
  •  Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model. Ogawa K,Mukai T,Asano D,Kawashima H,Kinuya S,Shiba K,Hashimoto K,Mori H,Saji H J Nucl Med 48 1 122-7
  •  Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model. Kinuya S,Yokoyama K,Fukuoka M,Hiramatsu T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N Nucl Med Commun 28 2 129-33
  •  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. Nakajima K,Matsubara K,Ishikawa T,Motomura N,Maeda R,Akhter N,Okuda K,Taki J,Kinuya S J Nucl Cardiol 14 6 843-51
  •  The sentinel node concept in prostate cancer: Present reality and future prospects. Egawa M,Fukuda M,Takashima H,Misaki T,Kinuya K,Terahata S Indian J Urol 24 4 451-6
  •  Cardiac scintigraphic findings of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A case report. Matsuo S,Nakajima K,Kinuya S,Sato Y,Matsumoto N,Horie M Exp Clin Cardiol 13 2 93-5
  •  Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Nakajima K,Yoshita M,Matsuo S,Taki J,Kinuya S Q J Nucl Med Mol Imaging 52 4 378-87
  •  Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBG SPECT and CT images. Kizu H,Takayama T,Tsushima H,Noguchi A,Nakajima K,Onoguchi M,Kinuya S J Nucl Med Technol 36 4 186-8
  •  Potential usefulness of D2R reporter gene imaging by IBF as gene therapy monitoring for cerebellar neurodegenerative diseases. Shiba K,Torashima T,Hirai H,Ogawa K,Akhter N,Nakajima K,Kinuya S,Mori H J Cereb Blood Flow Metab 29 2 434-40
  •  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations. Matsuo S,Nakajima K,Okuda K,Kawano M,Ishikawa T,Hosoya T,Taki J,Kinuya S Eur J Nucl Med Mol Imaging 36 4 560-6
  •  [Assessment for the image interpretation of 111In-ibritumomab tiuxetan in the phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma]. Oriuchi N,Koizumi K,Koizumi M,Terui S,Yamaura H,Imai Y,Kaneta T,Nawano S,Kubo A,Nishimura T,Kinuya S,Tobinai K,Endo K Kaku Igaku 45 2 99-113
  •  Regional wall thickening in gated myocardial perfusion SPECT in a Japanese population: effect of sex, radiotracer, rotation angles and frame rates. Akhter N,Nakajima K,Okuda K,Matsuo S,Yoneyama T,Taki J,Kinuya S Eur J Nucl Med Mol Imaging 35 9 1608-15
  •  [Guideline draft of appropriate use of 131I-MIBG for internal radiotherapy of neuroendocrine tumors]. Nakajo M,Yoshinaga K,Oriuchi N,Kinuya S,Yokoyama K,Yamaguchi T,Drafting Committee for Guideline of Internal Radiotherapy with 131I-MIBG,Japanese Society of Nuclear Medicine in Oncology and Immunology,Japanese Society of Nuclear Medicine Kaku Igaku 45 1 suppl 1-40
  •  A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging. Akhter N,Shiba K,Ogawa K,Tsuji S,Kinuya S,Nakajima K,Mori H Nucl Med Biol 35 1 29-34
  •  Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice. Yagi Y,Fushida S,Harada S,Tsukada T,Kinoshita J,Oyama K,Fujita H,Ninomiya I,Fujimura T,Kayahara M,Kinuya S,Yashiro M,Hirakawa K,Ohta T Cancer Chemother Pharmacol 66 4 745-53
  •  [The role of / 18FDG PET/CT for the initial staging and therapy in primary breast cancer]. Inokuchi M,Furukawa H,Kayahara M,Ohta T,Kawashima H,Taki J,Kinuya S Gan To Kagaku Ryoho 36 13 2526-31
  •  Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site. Ogawa K,Kawashima H,Kinuya S,Shiba K,Onoguchi M,Kimura H,Hashimoto K,Odani A,Saji H Ann Nucl Med 23 10 843-8
  •  Esophageal transit scintigraphy and structured questionnaire in patients with systemic sclerosis with endoscopically proven reflux esophagitis. Nakajima K,Inaki A,Hiramatsu T,Hasegawa M,Fujimoto M,Takehara K,Kinuya S Ann Nucl Med 23 9 771-6
  •  Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy. Ogawa K,Shiba K,Akhter N,Yoshimoto M,Washiyama K,Kinuya S,Kawai K,Mori H Cancer Sci 100 11 2188-92
  •  Clinical usefulness of novel cardiac MDCT/SPECT fusion image. Matsuo S,Nakajima K,Akhter N,Wakabayashi H,Taki J,Okuda K,Kinuya S Ann Nucl Med 23 6 579-86
  •  [Recent topics in targeted radiotherapy: metastron, zevalin and thyroid cancer]. Nihon Hoshasen Gijutsu Gakkai Zasshi 65 5 659-67
  •  Attenuation correction of myocardial SPECT by scatter-photopeak window method in normal subjects. Okuda K,Nakajima K,Motomura N,Kubota M,Yamaki N,Maeda H,Matsuo S,Kinuya S Ann Nucl Med 23 5 501-6
  •  Nuclear medicine practice in Japan: a report of the sixth nationwide survey in 2007. Kuwabara Y,Koizumi K,Ushijima Y,Kinuya S,Kinomura S,Suga K,Takeoka H,Takeda T,Toyama H,Arao Y,Nishiyama Y,Murakami K,Morita K Ann Nucl Med 23 2 209-15
  •  Gated myocardial perfusion SPECT for preoperative risk stratification in patients with noncardiac vascular disease. Kayano D,Nakajima K,Ohtake H,Kinuya S Ann Nucl Med 23 2 173-81
  •  The importance of population-specific normal database for quantification of myocardial ischemia: comparison between Japanese 360 and 180-degree databases and a US database. Nakajima K,Okuda K,Kawano M,Matsuo S,Slomka P,Germano G,Kinuya S J Nucl Cardiol 16 3 422-30
  •  Potential usefulness of D2R reporter gene imaging by IBF as gene therapy monitoring for cerebellar neurodegenerative diseases. Shiba K,Torashima T,Hirai H,Ogawa K,Akhter N,Nakajima K,Kinuya S,Mori H J Cereb Blood Flow Metab 29 2 434-40
  •  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations. Matsuo S,Nakajima K,Okuda K,Kawano M,Ishikawa T,Hosoya T,Taki J,Kinuya S Eur J Nucl Med Mol Imaging 36 4 560-6
  •  Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification. Wakabayashi H,Nakajima K,Fukuoka M,Inaki A,Nakamura A,Kayano D,Kinuya S Ann Nucl Med
  •  Quantification of myocardial perfusion SPECT using freeware package (cardioBull). Okuda K,Nakajima K,Hosoya T,Ishikawa T,Matsuo S,Kawano M,Taki J,Kinuya S Ann Nucl Med
  •  Esophageal transit study using a sliding sum image: application to patients with probable and definite systemic sclerosis. Nakajima K,Hasegawa M,Inaki A,Wakabayashi H,Hosoya T,Takehara K,Kinuya S Ann Nucl Med 25 5 325-31
  •  Clinical use of nuclear cardiology in the assessment of heart failure. Matsuo S,Nakajima K,Kinuya S World J Cardiol 2 10 344-56
  •  Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma. Fukuoka M,Taki J,Mochizuki T,Kinuya S Clin Nucl Med 36 1 1-7
  •  Evaluation of the Olfactory Nerve Transport Function by SPECT-MRI Fusion Image with Nasal Thallium-201 Administration. Shiga H,Taki J,Yamada M,Washiyama K,Amano R,Matsuura Y,Matsui O,Tatsutomi S,Yagi S,Tsuchida A,Yoshizaki T,Furukawa M,Kinuya S,Miwa T Mol Imaging Biol
  •  Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. Okuda K,Nakajima K,Hosoya T,Ishikawa T,Konishi T,Matsubara K,Matsuo S,Kinuya S J Nucl Cardiol 18 1 82-9
  •  Identification of myocardial damage in systemic sclerosis: a nuclear cardiology approach. Nakajima K,Matsuo S,Hasegawa M,Kinuya S,Takehara K Int J Rheumatol 2010
  •  123I-metaiodobenzylguanidine imaging in the era of implantable cardioverter defibrillators: beyond ejection fraction. Matsunari I,Taki J,Nakajima K,Kinuya S J Nucl Med 51 8 1171-3
  •  Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: assessment by 125I-anti-tenascin-C antibody imaging. Taki J,Inaki A,Wakabayashi H,Imanaka-Yoshida K,Ogawa K,Hiroe M,Shiba K,Yoshida T,Kinuya S J Nucl Med 51 7 1116-22
  •  Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Matsunari I,Aoki H,Nomura Y,Takeda N,Chen WP,Taki J,Nakajima K,Nekolla SG,Kinuya S,Kajinami K Circ Cardiovasc Imaging 3 5 595-603
  •  I-131 uptake in a thymic cyst. Kayano D,Michigishi T,Ichiyanagi K,Inaki A,Kinuya S Clin Nucl Med 35 6 438-9
  •  Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas. Taki J,Inaki A,Wakabayashi H,Sumiya H,Tsuchiya H,Zen Y,Kinuya S Clin Nucl Med 35 3 154-9
  •  Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice. Yagi Y,Fushida S,Harada S,Tsukada T,Kinoshita J,Oyama K,Fujita H,Ninomiya I,Fujimura T,Kayahara M,Kinuya S,Yashiro M,Hirakawa K,Ohta T Cancer Chemother Pharmacol 66 4 745-53
  •  Cause of apical thinning on attenuation-corrected myocardial perfusion SPECT. Okuda K,Nakajima K,Matsuo S,Wakabayashi H,Taki J,Kinuya S Nucl Med Commun
  •  Low-dose 123I-metaiodobenzylguanidine diagnostic scan is inferior to 131I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma. Kayano D,Taki J,Fukuoka M,Wakabayashi H,Inaki A,Nakamura A,Kinuya S Nucl Med Commun 32 10 941-6
  •  The relationship between stress-induced myocardial ischemia and coronary artery atherosclerosis measured by hybrid SPECT/CT camera. Matsuo S,Nakajima K,Okuda K,Kinuya S Ann Nucl Med
  •  Targeted alpha therapy with 223Ra for castration-resistant bone metastases of prostate cancer 33 4 431-441 2017
  •  Comparison of diagnostic performance of four software packages for phase dyssynchrony analysis in gated myocardial perfusion SPECT. Okuda K, Nakajima K, Matsuo S, Kashiwaya S, Yoneyama H, Shibutani T, Onoguchi M, Hashimoto M, Kinuya S. EJNMMI Res 2017
  •  去勢抵抗性前立腺がん骨転移に対する223Raα線内用療法 Clinical Imagiology 33 4 431-441 2017/04
  •  Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases Uemura H, Uemura H, Matsubara N, Kinuya S, Hosono M, Yajima Y, Doi T Int J Clin Oncol 2017/05/06
  •  Innovative exercise device for the abdominal trunk muscles: An early validation study. Kato S, Murakami H, Inaki A, Mochizuki T, Demura S, Nakase J, Yoshioka K, Yokogawa N, Igarashi T, Takahashi N, Yonezawa N, Kinuya S, Tsuchiya H. PLoS One. 12 2 e0172934 2017
  •  Creation and characterization of normal myocardial perfusion imaging databases using the IQ·SPECT system. Okuda K, Nakajima K, Matsuo S, Kondo C, Sarai M, Horiguchi Y, Konishi T, Onoguchi M, Shimizu T, Kinuya S. J Nucl Cardiol 10.1007/s12350-016-0770-2 2017
  •  Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis. Okuda K, Nakajima K, Matsuo S, Kondo C, Sarai M, Horiguchi Y, Konishi T, Onoguchi M, Shimizu T, Kinuya S. Ann Nucl Med 2017
  •  Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology. Shibata H, Kato S, Sekine I, Abe K, Araki N, Iguchi H, Izumi T, Inaba Y, Osaka I, Kato S, Kawai A, Kinuya S, Kodaira M, Kobayashi E, Kobayashi T, Sato J, Shinohara N, Takahashi S, Takamatsu Y, Takayama K, Takayama K, Tateishi U, Nagakura H, Hosaka M, Morioka H, Moriya T, Yuasa T, Yurikusa T, Yomiya K, Yoshida M. ESMO Open 1 2 e000037 2016
  •  New section in EJNMMI and Annals of Nuclear Medicine. Carrió I, Kinuya S. Ann Nucl Med.  30 9 593 2016
  •  Evaluation of cytological radiation damage to lymphocytes after I-131 metaiodobenzylguanidine therapy by the cytokinesis-blocked micronucleus assay. Watanabe N, Yokoyama K, Kinuya S, Tonami H. Ann Nucl Med. 30 9 624-628 2016
  •  Molecular Imaging for Personalized Medicine. Russell J, Tian J, Kinuya S, Shen B, Li XF. Biomed Res Int. 5170159 2016
  •  Development of a myocardial phantom and analysis system toward the standardization of myocardial SPECT image across institutions. Shibutani T, Onoguchi M, Katafuchi T, Kinuya S. Ann Nucl Med 30 10 699-707 2016
  •  Reducing the small-heart effect in pediatric gated myocardial perfusion single-photon emission computed tomography. Yoneyama H, Nakajima K, Okuda K, Matsuo S, Onoguchi M, Kinuya S, Edenbrandt L. J Nucl Cardiol 2016
  •  Optimization of the filter parameters in (99m)Tc myocardial perfusion SPECT studies: the formulation of flowchart. Shibutani T, Onoguchi M, Yamada T, Kamida H, Kunishita K, Hayashi Y, Nakajima T, Kinuya S. Australas Phys Eng Sci Med 39 2 571-581 2016
  •  Changes in muscle activity after performing the FIFA 11+ programme part 2 for 4 weeks. Takata Y, Nakase J, Inaki A, Mochizuki T, Numata H, Oshima T, Kinuya S, Tsuchiya H. J Sports Sci 34 20 2011-2017 2016
  •  Comparison of phase dyssynchrony analysis using gated myocardial perfusion imaging with four software programs: Based on the Japanese Society of Nuclear Medicine working group normal database. Nakajima K, Okuda K, Matsuo S, Kiso K, Kinuya S, Garcia EV. J Nucl Cardiol. 2016
  •  Effects of the belt electrode skeletal muscle electrical stimulation system on lower extremity skeletal muscle activity: Evaluation using positron emission tomography. Numata H, Nakase J, Inaki A, Mochizuki T, Oshima T, Takata Y, Kinuya S, Tsuchiya H. J Orthop Sci 21 1 53-56 2016
  •  In Vivo Differences between Two Optical Isomers of Radioiodinated o-iodo-trans-decalinvesamicol for Use as a Radioligand for the Vesicular Acetylcholine Transporter. Uno I, Kozaka T, Miwa D, Kitamura Y, Azim MA, Ogawa K, Taki J, Kinuya S, Shiba K. PLoS One. 11 1 e0146719 2016
  •  Simultaneous acquisition of (99m)Tc- and (123)I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors. Simultaneous acquisition of (99m)Tc- and (123)I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors. Ann Nucl Med 30 4 263-271 2016
  •  Correlation between apoptosis and left ventricular remodeling in subacute phase of myocardial ischemia and reperfusion. Wakabayashi H, Taki J, Inaki A, Shiba K, Matsunari I, Kinuya S. EJNMMI Res 5 1 72 2015
  •  Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter. Kitamura Y, Kozaka T, Miwa D, Uno I, Azim MA, Ogawa K, Taki J, Kinuya S, Shiba K. Ann Nucl Med 30 2 122-129 2016
  •  Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction Hideki Shiga, Junichi Taki, Okuda Koichi, Naoto Watanabe, Hisao Tonami, HIdeaki Nakagawa, Seigo Kinuya, Takaki Miwa Scientific Repoarts 7 3581 2017/06/15
  •  Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy. Kusakabe K,Yokoyama K,Ito K,Shibuya H,Kinuya S,Ito M,Higashi T,Togawa T,Koizumi K,Yoshimura M,Uchiyama M,Okamoto T,Kanaya S,Kanaya K,Yoneyama T,Ikebuchi H,Yanagida S,Shibata K,Segawa K,Yamamoto A Ann Nucl Med 26 4 370-8
  •  Improvement of the (99m)Tc-ECD brain uptake ratio (BUR) method for measurement of cerebral blood flow. Ito S,Takaki A,Inoue S,Tomiguchi S,Shiraishi S,Akiyama Y,Sasaki T,Odajima S,Teraoka S,Hosoya T,Soma T,Miyazaki Y,Kinuya S,Yamashita Y Ann Nucl Med 26 4 351-8
  •  A nuclear power plant accident in Fukushima: what should we do? Ann Nucl Med 26 2 113-4
  •  Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective. Higashi T,Kudo T,Kinuya S Ann Nucl Med 26 2 99-112
  •  Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors. Wakabayashi H,Taki J,Inaki A,Sumiya H,Zen Y,Tsuchiya H,Kinuya S Clin Nucl Med 37 1 1-8
  •  Optimization of iterative reconstruction parameters with attenuation correction, scatter correction and resolution recovery in myocardial perfusion SPECT/CT. Okuda K,Nakajima K,Yamada M,Wakabayashi H,Ichikawa H,Arai H,Matsuo S,Taki J,Hashimoto M,Kinuya S Ann Nucl Med
  •  Prognostic values of initial responses to low-dose (131)I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma. Wakabayashi H,Taki J,Inaki A,Nakamura A,Kayano D,Fukuoka M,Matsuo S,Nakajima K,Kinuya S Ann Nucl Med 27 9 839-46
  •  Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases. Wakabayashi H,Nakajima K,Mizokami A,Namiki M,Inaki A,Taki J,Kinuya S Ann Nucl Med 27 9 802-7
  •  Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes. Doai M,Watanabe N,Takahashi T,Taniguchi M,Tonami H,Iwabuchi K,Kayano D,Fukuoka M,Kinuya S Ann Nucl Med 27 3 233-8
  •  Improved Detection of Sentinel Lymph Nodes in SPECT/CT Images Acquired Using a Low- to Medium-Energy General-Purpose Collimator. Yoneyama H,Tsushima H,Kobayashi M,Onoguchi M,Nakajima K,Kinuya S Clin Nucl Med
  •  14C-Methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion. Taki J,Wakabayashi H,Inaki A,Imanaka-Yoshida K,Hiroe M,Ogawa K,Morooka M,Kubota K,Shiba K,Yoshida T,Kinuya S J Nucl Med 54 3 431-6
  •  Quantification of myocardial perfusion SPECT using freeware package (cardioBull). Okuda K,Nakajima K,Hosoya T,Ishikawa T,Matsuo S,Kawano M,Taki J,Kinuya S Ann Nucl Med 25 8 571-9
  •  Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma. Fukuoka M,Taki J,Mochizuki T,Kinuya S Clin Nucl Med 36 1 1-7
  •  Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. Okuda K,Nakajima K,Hosoya T,Ishikawa T,Konishi T,Matsubara K,Matsuo S,Kinuya S J Nucl Cardiol 18 1 82-9
  •  Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification. Wakabayashi H,Nakajima K,Fukuoka M,Inaki A,Nakamura A,Kayano D,Kinuya S Ann Nucl Med 25 9 609-15
  •  Cause of apical thinning on attenuation-corrected myocardial perfusion SPECT. Okuda K,Nakajima K,Matsuo S,Wakabayashi H,Taki J,Kinuya S Nucl Med Commun 32 11 1033-9
  •  Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma. Kayano D,Taki J,Fukuoka M,Wakabayashi H,Inaki A,Nakamura A,Kinuya S Nucl Med Commun 32 10 941-6
  •  Tc-99m human serum albumin lymphoscintigraphy with SPECT/CT in chylothorax. Kayano D,Taki J,Wakabayashi H,Kinuya S Clin Nucl Med 36 11 1056-7
  •  Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma. Wakabayashi H,Taki J,Inaki A,Nakamura A,Kayano D,Fukuoka M,Matsuo S,Nakajima K,Kinuya S Ann Nucl Med
  •  Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases. Wakabayashi H,Nakajima K,Mizokami A,Namiki M,Inaki A,Taki J,Kinuya S Ann Nucl Med
  •  Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes. Doai M,Watanabe N,Takahashi T,Taniguchi M,Tonami H,Iwabuchi K,Kayano D,Fukuoka M,Kinuya S Ann Nucl Med 27 3 233-8
  •  Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy. Kusakabe K,Yokoyama K,Ito K,Shibuya H,Kinuya S,Ito M,Higashi T,Togawa T,Koizumi K,Yoshimura M,Uchiyama M,Okamoto T,Kanaya S,Kanaya K,Yoneyama T,Ikebuchi H,Yanagida S,Shibata K,Segawa K,Yamamoto A Ann Nucl Med 26 4 370-8
  •  Improved Detection of Sentinel Lymph Nodes in SPECT/CT Images Acquired Using a Low- to Medium-Energy General-Purpose Collimator. Yoneyama H,Tsushima H,Kobayashi M,Onoguchi M,Nakajima K,Kinuya S Clin Nucl Med
  •  Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors. Wakabayashi H,Taki J,Inaki A,Sumiya H,Zen Y,Tsuchiya H,Kinuya S Clin Nucl Med 37 1 1-8
  •  Assessment of doxorubicin cardiac toxicity using gated ⁹⁹mTc-hexakis-2-methoxyisobutylisonitrile myocardial single photon emission computed tomography: wall thickening and motion abnormalities can be an early sign of cardiac involvement. Wakabayashi H,Taki J,Inaki A,Sumiya H,Tsuchiya H,Kinuya S Circ J 76 5 1190-6
  •  Improved quantification of small hearts for gated myocardial perfusion imaging. Nakajima K,Okuda K,Nyström K,Richter J,Minarik D,Wakabayashi H,Matsuo S,Kinuya S,Edenbrandt L Eur J Nucl Med Mol Imaging 40 8 1163-70
  •  I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma. Sato Y,Kurosawa H,Fukushima K,Okuya M,Hagisawa S,Sugita K,Arisaka O,Inaki A,Wakabayashi H,Nakamura A,Fukuoka M,Kayano D,Kinuya S Int J Med Sci 38 53
  •  14C-Methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion. Taki J,Wakabayashi H,Inaki A,Imanaka-Yoshida K,Hiroe M,Ogawa K,Morooka M,Kubota K,Shiba K,Yoshida T,Kinuya S J Nucl Med 54 3 431-6
  •  Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma. Inaki A,Taki J,Wakabayashi H,Sumiya H,Zen Y,Tsuchiya H,Kinuya S Ann Nucl Med 26 7 545-50 2012
  •  Esophageal transit study using a sliding sum image: application to patients with probable and definite systemic sclerosis. Nakajima K,Hasegawa M,Inaki A,Wakabayashi H,Hosoya T,Takehara K,Kinuya S Ann Nucl Med 25 5 325-31
  •  The relationship between stress-induced myocardial ischemia and coronary artery atherosclerosis measured by hybrid SPECT/CT camera. Matsuo S,Nakajima K,Okuda K,Kinuya S Ann Nucl Med 25 9 650-6
  •  A nuclear power plant accident in Fukushima: what should we do? Ann Nucl Med 26 2 113-4
  •  Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma. Inaki A,Taki J,Wakabayashi H,Sumiya H,Zen Y,Tsuchiya H,Kinuya S Ann Nucl Med 26 7 545-50
  •  [Targeted radionuclide therapy - where should we go ?]. Gan To Kagaku Ryoho 40 2 133-8
  •  [Targeted radionuclide therapy - where should we go ?]. Gan To Kagaku Ryoho 40 2 133-8
  •  Assessment of doxorubicin cardiac toxicity using gated ⁹⁹mTc-hexakis-2-methoxyisobutylisonitrile myocardial single photon emission computed tomography: wall thickening and motion abnormalities can be an early sign of cardiac involvement. Wakabayashi H,Taki J,Inaki A,Sumiya H,Tsuchiya H,Kinuya S Circ J 76 5 1190-6
  •  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Nakajima K,Okuda K,Matsuo S,Yoshita M,Taki J,Yamada M,Kinuya S Eur J Nucl Med Mol Imaging 39 1 113-9
  •  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Nakajima K,Okuda K,Matsuo S,Yoshita M,Taki J,Yamada M,Kinuya S Eur J Nucl Med Mol Imaging 39 1 113-9
  •  Improved quantification of small hearts for gated myocardial perfusion imaging. Nakajima K,Okuda K,Nyström K,Richter J,Minarik D,Wakabayashi H,Matsuo S,Kinuya S,Edenbrandt L Eur J Nucl Med Mol Imaging 40 8 1163-70
  •  I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma. Sato Y,Kurosawa H,Fukushima K,Okuya M,Hagisawa S,Sugita K,Arisaka O,Inaki A,Wakabayashi H,Nakamura A,Fukuoka M,Kayano D,Kinuya S Ital J Pediatr 38 53
  •  Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer. Kobayashi M,Wakabayashi H,Kojima H,Konishi T,Okuda K,Yoneyama H,Kayano D,Tobisaka M,Tsushima H,Onoguchi M,Kawai K,Kinuya S Hell J Nucl Med 16 3 175-80
  •  Assessment of olfactory nerve by SPECT-MRI image with nasal thallium-201 administration in patients with olfactory impairments in comparison to healthy volunteers. Shiga H,Taki J,Washiyama K,Yamamoto J,Kinase S,Okuda K,Kinuya S,Watanabe N,Tonami H,Koshida K,Amano R,Furukawa M,Miwa T PLoS One 8 2 e57671 2013
  •  Whole Body Muscle Activity during the FIFA 11+ Program Evaluated by Positron Emission Tomography. Nakase J,Inaki A,Mochizuki T,Toratani T,Kosaka M,Ohashi Y,Taki J,Yahata T,Kinuya S,Tsuchiya H PLoS One 8 9 e73898 2013
  •  Assessment of olfactory nerve by SPECT-MRI image with nasal thallium-201 administration in patients with olfactory impairments in comparison to healthy volunteers. Shiga H,Taki J,Washiyama K,Yamamoto J,Kinase S,Okuda K,Kinuya S,Watanabe N,Tonami H,Koshida K,Amano R,Furukawa M,Miwa T PLoS One 8 2 e57671 2013
  •  Evaluation of the olfactory nerve transport function by SPECT-MRI fusion image with nasal thallium-201 administration. Shiga H,Taki J,Yamada M,Washiyama K,Amano R,Matsuura Y,Matsui O,Tatsutomi S,Yagi S,Tsuchida A,Yoshizaki T,Furukawa M,Kinuya S,Miwa T Mol Imaging Biol 13 6 1262-6 2011
  •  Phase II study of radium‑223 dichloride in Japanese patients with symptomatic castration‑resistant prostate cancer Nobuaki Matsubara, Satsohi Nagamori, Yoshiaki Wakumoto, Hirotsugu Uemura, Go Kimura, Akira Yokomizo,Hiroaki Kikukawa, Atsushi Mizokami, Takeo Kosaka, Naoya Masumori,Yoshihide Kawasaki, Junji Yonese,Yasutomo Nasu,Satoshi Fukasawa,Takayuki Sugiyama, Seigo Kinuya,Makoto Hosono,Iku Yamaguchi,Hirokazu Tsutsui,Hiroji Uemura Int J Clin Oncol 2017
  •  甲状腺癌の放射性ヨウ素内用療法におけるRI 治療病室稼働状況の実態調査報告(第4 報) 54 1 579–586 2017
  •  A Report on Health Resource Use in Internal Radiation Therapy with Radium Chloride (223Ra) (2nd Survey) Seigo KINUYA,Katsuhiko KATO,Takeshi KAMIOKA,Toshiyuki SHIMMURA,Yoshinori MATOBA,Kengo ITO, KAKUIGAKU 54 1 603-621 2017

Conference Presentations

  • 臨床応用(conference: I-131(1,110MBq)による残存甲状腺破壊(アブレーション)の外来治療における適正使用に関する講習会)(2017/09/02)
  • RI内用療法の現状と未来 (2017/09/09)
  • 放射性ヨウ素治療の今後の方向性 (2017/09/02)
  • 腫瘍核医学における最新トピックス (2017/08/31)
  • 放射性ヨウ素治療の現状から今後の甲状腺癌治療を考える (conference:京都放射性ヨウ素治療研究会)(2017/07/21)

show all

  • α線内用療法の有効性(臨床応用に関する基礎的事項)(conference:塩化ラジウム(Ra223)注射液を用いたRI内用療法における適正使用に関する安全取扱講習会)(2017/07/22)
  • RAI(radioactive iodine)不応性を克服できないか?(2017/07/15)
  • Effects of Fukushima Daiichi Nuclear Disaster (conference:Korean Medical Association)(2017/07/01)
  • Radioiodine therapy for thyroid cancer - things we have to think about for the future (conference:Daegyeong Chapter of the Korean Society of Nuclear Medicine)(2017/06/30)
  • Radioiodine therapy and imaging guided strategy(conference:24th Asia Pacific Cancer Conference)(2017/06/23)
  • Radionuclide theranostics(2017/06/20)
  • 放射性ヨウ素治療の現状から今後の甲状腺癌治療を考える(2017/06/17)
  • Radionuclide theranostics(2017/06/20)
  • 内用療法一緒にやってみる?(2017/05/27)
  • Concept of targeted radionuclide therapy For the future of interdisciplinary collaboration (conference:Translational Immunology - from target to therapy IV)(2017/05/05)
  • Targeted radionuclide therapy with 131I-MIBG for malignant neuroendcrine tumors: experience for 14 years(conference:World Association of Radiopharmaceutical and Molecular Therapy)(2015/10/31)
  • 基礎と安全管理 放射性同位元素の取扱(2017/04/22)
  • RI内用療法(本邦における最近のトピック)(2017/04/23)
  • 分子標的薬の開始基準を考える From 核医学的 point of view (2017/03/31)
  • Recent advance in targeted radionuclide therapy: toward individualized evidence based medicine(conference:15th International Congress of Radiation Reseach)(2015/05/26)
  • Present status and strategy to develop targeted radionuclide therapy in Japan(conference:Asia Regional Cooperative Council of Nuclear Medicine)(2016/07/15)
  • Recent basic researches on targeted radionuclide therapy in Japan(conference:11th International Conference on Radiopharmaceuticlas)(2016/11/14)
  • Establishment of National Congress of Targeted Radionuclide Therapy(conference:17th Chinese Symposium on Nuclear Cardiology)(2016/07/01)
  • Tharanostic use of "オクトレオスキャン”(conference:NET Progress Japan)(2017/02/25)
  • Way to develop targeted radionuclide therapy in Japan(conference:The 3rd International Symposium on Targeted Radionuclide Therapy)(2017/02/12)
  • Radionuclide theranostics(2017/06/20)

Arts and Fieldwork

Patent

Theme to the desired joint research

Grant-in-Aid for Scientific Research

○「進行消化器癌に対するα線核種内照射療法による治療戦略の確立」(2016-2018) 
○「悪性神経内分泌腫瘍に対する131I-MIBG内照射療法の開発」(2015-2017) 
○「悪性神経内分泌腫瘍に対する分子生物学的・組織学的特徴に基づいた集学的内照射療法」(2010-2011) 
○「悪性神経内分泌腫瘍に対する血管新生阻害下内用療法:基礎研究から臨床応用へ」(2007-2009) 
○「癌細胞膜アビジン発現とスカベンジャー受容体内在化による特異的普遍的内照射療法の開発」(2004-2006) 
○「放射性化合物内照射療法と血管新生阻害療法との同調効果による癌転移巣の制御」(2002-2003) 
○「DNA修復阻害・腫瘍内酸素化改善による放射性医薬品内照射療法の抗腫瘍効果増強」(2000-2001) 
○「腫瘍血行動態改善による放射能標識モノクローナル抗体の治療効果増強に関する研究」(1997-1998) 

Classes (Bachelors)

○Nuclean Medicine(BSL)(2017)
○Nuclean Medicine(BSL)(2016)

Classes (Graduate Schools)

○Exploring and preventive diagnostics(2017)
○Biotracer Medicine(2017)
○Biotracer Medicine(2017)
○Biotracer Medicine(2017)
○Exploring and preventive diagnostics(2016)
○Biotracer Medicine(2016)
○Biotracer Medicine(2016)
○Biotracer Medicine(2016)

International Project

International Students

Lecture themes

Others (Social Activities)

To Page Top